z-logo
Premium
Influence of Ligand and Nuclearity on the Cytotoxicity of Cyclometallated C^N^C Platinum(II) Complexes
Author(s) -
Kergreis Angélique,
Lord Rianne M.,
Pike Sarah J.
Publication year - 2020
Publication title -
chemistry – a european journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.687
H-Index - 242
eISSN - 1521-3765
pISSN - 0947-6539
DOI - 10.1002/chem.202002517
Subject(s) - platinum , pyrazine , chemistry , ligand (biochemistry) , cytotoxicity , cisplatin , selectivity , stereochemistry , triphenylphosphine , butane , medicinal chemistry , receptor , biochemistry , biology , in vitro , chemotherapy , catalysis , genetics
Abstract A series of cyclometallated mono‐ and di‐nuclear platinum(II) complexes and the parent organic ligand, 2,6‐diphenylpyridine 1 (HC^N^CH), have been synthesized and characterized. This library of compounds includes [(C^N^C)Pt II ( L )] ( L =dimethylsulfoxide (DMSO) 2 and triphenylphosphine (PPh 3 ) 3 ) and [((C^N^C)Pt II ) 2 ( L‘ )] (where L‘ = N ‐heterocycles (pyrazine (pyr) 4 , 4,4‘‐bipyridine (4,4‘‐bipy) 5 or diphosphine (1,4‐bis(diphenylphosphino)butane (dppb) 6 ). Their cytotoxicity was assessed against four cancerous cell lines and one normal cell line, with results highlighting significantly increased antiproliferative activity for the dinuclear complexes ( 4 – 6 ), when compared to the mononucleated species ( 2 and 3 ). Complex  6 is the most promising candidate, displaying very high selectivity towards cancerous cells, with selectivity index (SI) values >29.5 (A2780) and >11.2 (A2780cisR), and outperforming cisplatin by >4‐fold and >18‐fold, respectively.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom